Think Forward with iLS in the sale of its stake in Welcare – iLS Milan

•Securitisation Watch•iLS Law Firm of the Year for NPLs•Norman and Fabrizio co-author legal article discussing controversial case-law on ability of special servicers to carry out judicial recovery•iLS with DBRS Morningstar in the rating of the first systemic NPL securitisation of the Republic of San Marino•iLS at the 9th International Funds Summit & EXPO in Cyprus•Norman and Fabrizio co-author legal article on latest trends of Italian case law about transfers of receivables in bulk•Norman Pepe’s article on BeBeez regarding the causes and consequences of the potential NPLs market reform•Project Mugello•iLS ranked in the TopLegal Capital Markets 2022 survey•Norman presents iLS at the 2022 South Europe NPL Management Summit in Athens•iLS with illimity in the real estate refinancing of Relais Borgo Santo Pietro•Norman and Fabrizio co-author legal article on new rules for risk retention requirement in NPE securitisations•iLS assisted Bonaudo S.p.A. in the acquisition of Conceria Conti S.p.A.•Conor Downey joins iLS as new partner•iLS in the sixth NPL securitisation backed by “GACS” guarantee of BCC Banca Iccrea•iLS with illimity in a real estate refinancing transaction in the hotelerie sector•Real Estate Securitisation as a real estate financing tool in Italy•iLS ranked in the TopLegal Capital Markets 2022 survey•Elena Cannazza joins iLS as new partner•ICCREA GACS V•Think Forward with iLS in the sale of its stake in Welcare•iLS opens its Milan office•Project Sandokan 2•Project Arya•iLS “Independent Italian Desk of the Year”•ICCREA GACS IV•Norman and Fabrizio co-author legal article on RE securitisation•Norman and Fabrizio interviewed by Capital Structure – 06/2020•Covid-19’s impact on the Italian Npl market•GACS and secondary market transactions•Two new tools for reperforming strategies

Marco Pallucchini advises Think Forward S.r.l. in its capacity as selling shareholder in the context of disposal of the majority of Welcare Group to Labomar.
Welcare is a company specializing in skincare and wound care medical products and devices, whilst Labomar is a Pharmaceutical Company listed on the “AIM Italia” regulated market.